Patzer Eric 4
4 · Aridis Pharmaceuticals, Inc. · Filed Jun 15, 2023
Insider Transaction Report
Form 4
Patzer Eric
Director
Transactions
- Exercise/Conversion
Common Stock
[F2]2023-06-05+12,000→ 714,132 total - Award
Stock Options
[F1]2023-05-04+30,000→ 146,862 totalExercise: $0.16Exp: 2033-05-04→ Common Stock (30,000 underlying) - Exercise/Conversion
Restricted Stock Units
[F2][F3]2023-06-05−12,000→ 12,000 total→ Common Stock (12,000 underlying)
Footnotes (3)
- [F1]50% of the options vest on the three month anniversary of the date of grant and the remainder vest on the six month anniversary of the date of grant.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]12,000 shares of Common Stock vested on June 5, 2023 and 12,000 will vest on 12/5/2023. In the event that the Reporting Person's employment is terminated without cause by the Issuer, the RSUs will immediately vest.
Signature
/s/ Eric Patzer|2023-06-15